Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Public Health Nutr. 2000 Dec;3(4A):509-14.

The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.

Author information

  • 1Department of Complementary Medicine, School of Postgraduate Medicine and Health Science, University of Exeter, UK. e.ernst@exeter.ac.uk

Abstract

OBJECTIVE:

Feverfew (Tanacetum parthenium L.) is a popular herbal remedy often advocated for the prevention of migraine. The aims of this systematic review are to update the evidence from rigorous clinical trials for or against the efficacy of feverfew for migraine prevention and to provide a safety profile of this herbal remedy.

DESIGN:

Literature searches were performed using the following databases: Medline, Embase, Biosis, CISCOM and the Cochrane Library (all from their inception to December 1999). Only randomized, placebo-controlled, double-blind trials of feverfew mono-preparations for the prevention of migraine in human subjects were included. All articles were read by two independent reviewers. Data were extracted in a pre-defined, standardized fashion. The methodological quality of the trials was evaluated by the Jadad score. For the assessment of safety issues, major reference texts were also consulted.

RESULTS:

Six trials met the inclusion/exclusion criteria. The majority favour feverfew over placebo. Yet important caveats exist. The data also suggest that feverfew is associated with only mild and transient adverse effects and few other safety concerns.

CONCLUSIONS:

Feverfew is likely to be effective in the prevention of migraine. There are no major safety problems.

PMID:
11276299
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cambridge University Press
    Loading ...
    Write to the Help Desk